James Cavanaugh - Oct 2, 2024 Form 4 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)

Role: Director
Signature: /s/ Douglas E. Onsi as attorney-in-fact for James Cavanaugh
Stock symbol: LPTX
Transactions as of: Oct 2, 2024
Transactions value $: $0
Form type: 4
Date filed: 10/4/2024, 05:23 PM
Previous filing: Jan 31, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LPTX	Stock Option (Right to Buy)	Award	$0	+25K		$0.00	25K	Oct 2, 2024	Common Stock	25K	$2.45	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of December 31, 2024, March 31, 2025, June 30, 2025, and September 30, 2025 for so long as the reporting person continues to be a director, consultant or service provider of the Company.

Content

The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of December 31, 2024, March 31, 2025, June 30, 2025, and September 30, 2025 for so long as the reporting person continues to be a director, consultant or service provider of the Company.